v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 219,596 $ 279,572
Short-term investments 35,300 47,745
Restricted cash 4,120 0
Accounts Receivable 3,042 1,078
Inventories 1,527 1,098
Note receivable 0 32,005
Deferred offering costs 663 1,782
Prepaid expenses and other current assets 7,917 4,949
Current assets of discontinued operations 0 31,690
Total current assets 272,165 399,919
Property and equipment, net 42,131 33,291
Natural gas properties 192,962 0
Operating lease right-of-use assets, net 5,593 1,464
Intangible assets 634 409
Goodwill 6,466 5,177
Lease receivable - noncurrent 4,044 426
Restricted cash 1,736 0
Equity method investments 24,855 0
Other investments 19,380 5,580
Other noncurrent assets 2,080 866
Noncurrent assets of discontinued operations 0 50,888
Total assets 572,046 498,020
Current liabilities:    
Accounts payable 5,704 3,814
Accrued expenses 8,074 4,414
Debt - current 54,513 584
Finance lease liabilities - current 178 167
Operating lease liabilities - current 920 544
Deferred revenue 882 882
Other current liabilities 9 501
Current liabilities of discontinued operations 0 21,790
Total current liabilities 70,280 32,696
Deferred tax liabilities 8,011 0
Convertible notes payable, at fair value 203,351 199,323
Debt - noncurrent 5,256 1,471
Finance lease liabilities - noncurrent 385 471
Operating lease liabilities - noncurrent 4,941 1,059
Deferred revenue - noncurrent 914 0
Other noncurrent liabilities 4,118 0
Noncurrent liabilities of discontinued operations 0 102
Total liabilities 297,256 235,122
Commitments and contingencies (Note 11)
Stockholders' equity    
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025 0 0
Common stock, $0.01 par value; 500,000,000 shares authorized, 130,284,092 shares issued and 130,148,698 shares outstanding as of June 30, 2026 and 111,677,771 shares issued and outstanding as of December 31, 2025 1,301 1,117
Treasury stock at cost 1 0
Additional paid-in capital 533,562 431,757
Accumulated deficit (272,837) (231,265)
Accumulated other comprehensive income 2,666 2,542
Total stockholders' equity attributed to ASP Isotopes Inc. stockholders 264,693 204,151
Noncontrolling interests in consolidated subsidiaries 10,097 58,747
Total stockholders' equity 274,790 262,898
Total liabilities and stockholders' equity $ 572,046 $ 498,020